Cargando…

Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways

Inflammation contributes to leukocyte migration, termed insulitis, and β-cell loss in type 1 diabetes (T1D). Naturally occurring anthraquinones are claimed as anti-inflammatory compounds; however, their actions are not clear. This study aimed to investigate the effect and mechanism of catenarin on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Ming-Yi, Lin, Yu-Ping, Yang, Bei-Chang, Jang, Yu-Song, Chiang, Chih-Kang, Mettling, Clément, Chen, Zeng-Weng, Sheu, Joen-Rong, Chang, Cicero L., Lin, Yea-Lih, Yang, Wen-Chin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291164/ https://www.ncbi.nlm.nih.gov/pubmed/22454693 http://dx.doi.org/10.1155/2012/982396

Ejemplares similares

An Update of Anthraquinone Derivatives Emodin, Diacerein, and Catenarin in Diabetes
por: Martorell, Miquel, et al.
Publicado: (2021)

Morus alba and active compound oxyresveratrol exert anti-inflammatory activity via inhibition of leukocyte migration involving MEK/ERK signaling
por: Chen, Yi-Ching, et al.
Publicado: (2013)

Mek1 and Mek2 Functional Redundancy in Erythropoiesis
por: Beuret, Laurent, et al.
Publicado: (2021)

Inhibition of GSK3 and MEK induced cancer stem cell generation via the Wnt and MEK signaling pathways
por: Liao, Shengtao, et al.
Publicado: (2018)

El jet's mek' /
por: Romero de Nieto, Carmen
Publicado: (1986)

DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways
por: Liu, Shilei, et al.
Publicado: (2020)

Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor
por: Küsters-Vandevelde, Heidi VN, et al.
Publicado: (2014)

RNA sequencing analysis to demonstrate Erk dependent and independent functions of Mek
por: Liu, Chang, et al.
Publicado: (2015)

MEK genomics in development and disease
por: Bromberg-White, Jennifer L., et al.
Publicado: (2012)

New features in MEK retinopathy
por: Tyagi, Pallavi, et al.
Publicado: (2018)

MEK inhibitors as a chemotherapeutic intervention in multiple myeloma
por: Chang-Yew Leow, C, et al.
Publicado: (2013)

The Role of Macrophages in T Cell–mediated Autoimmune Diabetes in Nonobese Diabetic Mice
por: Jun, Hee-Sook, et al.
Publicado: (1999)

Exostosin 1 Knockdown Induces Chemoresistance in MV3 Melanoma Cells by Upregulating JNK and MEK/ERK Signaling
por: Pfeifer, Vladlena, et al.
Publicado: (2023)

Phorbol esters induce PLVAP expression via VEGF and additional secreted molecules in MEK1‐dependent and p38, JNK and PI3K/Akt‐independent manner
por: Hamilton, B. JoNell, et al.
Publicado: (2018)

Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901
por: Shannon, Stephen, et al.
Publicado: (2017)

CRISPR/Cas9 Edited RAS & MEK Mutant Cells Acquire BRAF and MEK Inhibitor Resistance with MEK1 Q56P Restoring Sensitivity to MEK/BRAF Inhibitor Combo and KRAS G13D Gaining Sensitivity to Immunotherapy
por: Turner, Elizabeth, et al.
Publicado: (2022)

PPARγ and MEK Interactions in Cancer
por: Burgermeister, Elke, et al.
Publicado: (2008)

MEK and the inhibitors: from bench to bedside
por: Akinleye, Akintunde, et al.
Publicado: (2013)

Cisplatin inhibits MEK1/2
por: Yamamoto, Tetsu, et al.
Publicado: (2015)

MEK5 promotes lung adenocarcinoma
por: Sánchez-Fdez, Adrián, et al.
Publicado: (2019)

Current Development Status of MEK Inhibitors
por: Cheng, Ying, et al.
Publicado: (2017)

Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii
por: Kwon, Soo-Jung, et al.
Publicado: (2017)

Androgen treatment prevents diabetes in nonobese diabetic mice
Publicado: (1992)

SGLT1 Inhibition Attenuates Apoptosis in Diabetic Cardiomyopathy via the JNK and p38 Pathway
por: Lin, Na, et al.
Publicado: (2021)

Mutation Analysis of BRAF, MEK1 and MEK2 in 15 Ovarian Cancer Cell Lines: Implications for Therapy
por: Estep, Anne L., et al.
Publicado: (2007)

Identification and Characterization of a Novel Chemotype MEK Inhibitor Able to Alter the Phosphorylation State of MEK1/2
por: Yoshida, Takayuki, et al.
Publicado: (2012)

MEK Inhibitor U0126 Reverses Protection of Axons from Wallerian Degeneration Independently of MEK–ERK Signaling
por: Evans, Catherine, et al.
Publicado: (2013)

Direct binding of MEK1 and MEK2 to AKT induces Foxo1 phosphorylation, cellular migration and metastasis
por: Procaccia, Shiri, et al.
Publicado: (2017)

Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy
por: Booth, Andrew E. C., et al.
Publicado: (2020)

Relationship between postprandial endotoxemia in nonobese postmenopausal women and diabetic nonobese postmenopausal women
por: Zaman, Gaffar Sarwar, et al.
Publicado: (2015)

The MEK inhibitor U0126 ameliorates diabetic cardiomyopathy by restricting XBP1's phosphorylation dependent SUMOylation
por: Wang, Tao, et al.
Publicado: (2021)

JNK activation is essential for activation of MEK/ERK signaling in IL-1β-induced COX-2 expression in synovial fibroblasts
por: Kitanaka, Taku, et al.
Publicado: (2017)

Scattering of MCF7 Cells by Heregulin ß-1 Depends on the MEK and p38 MAP Kinase Pathway
por: Okoshi, Rintaro, et al.
Publicado: (2013)

Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition
por: van Houdt, Winan J., et al.
Publicado: (2010)

MEK inhibitors for the treatment of non-small cell lung cancer
por: Han, Jing, et al.
Publicado: (2021)

Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
por: Itoh, Naoto, et al.
Publicado: (1997)

Spontaneous Autoimmune Diabetes in Monoclonal T Cell Nonobese Diabetic Mice
por: Verdaguer, Joan, et al.
Publicado: (1997)

I-E+ nonobese diabetic mice develop insulitis and diabetes
Publicado: (1993)

Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse
Publicado: (1987)

Breaking self-tolerance in nonobese diabetic mice
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_k78rfpru4melvqi3cpduod1eru